10 Year evaluation of patients with severe uncontrolled allergic asthma treated with Omalizumab.

O. Ružicková-Kirchnerová (Pilsen, Czech Republic), P. Molácková (Pilsen, Czech Republic), M. Terl (Pilsen, Czech Republic), P. Vaník (Ceske Budejovice, Czech Republic), P. Panzner (Pilsen, Czech Republic)

Source: International Congress 2018 – Physiological and biological insights in asthma
Session: Physiological and biological insights in asthma
Session type: Thematic Poster
Number: 658
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Ružicková-Kirchnerová (Pilsen, Czech Republic), P. Molácková (Pilsen, Czech Republic), M. Terl (Pilsen, Czech Republic), P. Vaník (Ceske Budejovice, Czech Republic), P. Panzner (Pilsen, Czech Republic). 10 Year evaluation of patients with severe uncontrolled allergic asthma treated with Omalizumab.. 658

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: